Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MitoRx Therapeutics is a biopharmaceutical company with a first-in-class and first-in-target platform designed to potentially halt the progression of challenging diseases. Headquartered in Oxford and Exeter, UK, the company is initially concentrating on three rare indications while seeking partnerships for broader applications. MitoRx is advancing a pipeline of pre-clinical programs with its MTRX technology, which has demonstr...
MitoRx Therapeutics is a biopharmaceutical company with a first-in-class and first-in-target platform designed to potentially halt the progression of challenging diseases. Headquartered in Oxford and Exeter, UK, the company is initially concentrating on three rare indications while seeking partnerships for broader applications. MitoRx is advancing a pipeline of pre-clinical programs with its MTRX technology, which has demonstrated pharmacological utility in various in vivo models over more than a decade of research, as evidenced by over twenty publications.

List your booth number for exhibitions, ask us